Live Quote · NASDAQPGENHealthcare· Biotechnology

Precigen, Inc.

$4.21▲ 1.20%(+$0.05)
MKT CAP $1.51BNEXT EARNINGS Mar 24, 2027
50%
Bullish
TickerSpark Score
58/100
▌ Mixed
43
Valuation
95
Profitability
55
Growth
68
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a PGEN research report →

Analyst Price Target
$15.00+256.3% vs. today

Range $12 – $18

Analyst RatingBuy
11 Buy4 Hold1 Sell

Price Chart

+7.95% · this period
$8.56$5.83$3.10Nov 20May 26Nov 20
52-Week Range20% of range
Low
$3.04
Current
$4.21
High
$8.98